The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 672.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.446%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 672.00
BOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

31 Oct 2022 07:00

RNS Number : 5717E
Bodycote PLC
31 October 2022
 

31st October 2022

Bodycote plc

Appointment of Chief Financial Officer

 

Bodycote plc ("Bodycote") is pleased to announce the appointment of Ben Fidler as Chief Financial Officer designate and as a member of the Board of Bodycote as of 24th February 2023. Ben will take up the role of Chief Financial Officer on 1st May 2023, succeeding Dominique Yates who announced his intention to retire earlier this year.

 

Ben is currently the Deputy Chief Financial Officer of Rolls-Royce plc ("Rolls-Royce"), a position he has held since January 2021. Ben has spent five years with Rolls-Royce, previously holding the positions of Vice President of Business Performance and Director of Financial Planning and Analysis.

 

Prior to Rolls-Royce, Ben spent 20 years as an Aerospace & Defence equity research analyst, 18 of which were at Deutsche Bank. There he led a team which achieved consistent top rankings in external analyst surveys. Ben started his career as a strategy consultant at the LEK partnership. He is a graduate of the University of Oxford and holds a degree in Biochemistry.

 

Stephen Harris, Group Chief Executive of Bodycote plc, commented:

 

"We are delighted to welcome Ben to the Group. His experience as a senior executive at a FTSE 100 company, as well as his in-depth knowledge of our end markets, make him an excellent fit for Bodycote. He will be a great addition to the team and I look forward to working with him.

 

"We would also like to thank Dominique Yates. His contribution to Bodycote over the past six years has been invaluable. He will leave with our gratitude for the considerable effort he expended over this period. We wish him all the best for the future."

 

For further information, please contact:

 

Bodycote plc

Stephen Harris, Group Chief Executive

Dominique Yates, Chief Financial Officer

Tel No +44(0) 1625 505300

 

FTI Consulting

Richard Mountain / Susanne Yule

Tel No +44 (0) 2037271340

 

About Bodycote

With more than 165 accredited facilities in 22 countries, Bodycote is the world's largest provider of heat treatment and specialist thermal processing services. Bodycote improves the properties of metals and alloys for a wide range of manufacturing industries. Customers have entrusted their products to Bodycote's care for more than 30 years. For more information, visit

www.bodycote.com.

 

This notice is given in fulfilment of the obligation under paragraph 9.6.11R of the Listing Rules of the UK Listing Authority

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMMBFTMTMJBJT
Date   Source Headline
22nd Apr 20247:00 amPRNTransaction in Own Shares
19th Apr 20247:00 amPRNTransaction in Own Shares
18th Apr 20247:00 amPRNTransaction in Own Shares
17th Apr 20247:00 amPRNTransaction in Own Shares
16th Apr 20247:00 amPRNTransaction in Own Shares
15th Apr 20247:00 amPRNTransaction in Own Shares
12th Apr 20247:00 amPRNTransaction in Own Shares
11th Apr 20247:00 amPRNTransaction in Own Shares
10th Apr 20247:00 amPRNTransaction in Own Shares
9th Apr 20247:00 amPRNTransaction in Own Shares
8th Apr 20247:00 amPRNTransaction in Own Shares
5th Apr 20247:00 amPRNTransaction in Own Shares
4th Apr 20249:50 amPRNAnnual Financial Report
4th Apr 20247:00 amPRNTransaction in Own Shares
3rd Apr 20247:00 amPRNTransaction in Own Shares
2nd Apr 20249:47 amPRNHolding(s) in Company
2nd Apr 20249:41 amPRNHolding(s) in Company
2nd Apr 20248:35 amPRNTransaction in Own Shares
28th Mar 20247:00 amPRNTransaction in Own Shares
27th Mar 20247:00 amPRNTransaction in Own Shares
26th Mar 20247:00 amPRNTransaction in Own Shares
25th Mar 20243:07 pmPRNDirector/PDMR Shareholding
25th Mar 20247:00 amPRNTransaction in Own Shares
22nd Mar 20247:00 amPRNTransaction in Own Shares
21st Mar 20242:55 pmPRNDirector/PDMR Shareholding
21st Mar 20242:29 pmPRNDirector/PDMR Shareholding
21st Mar 20247:00 amPRNTransaction in Own Shares
20th Mar 20247:00 amPRNTransaction in Own Shares
19th Mar 202411:24 amPRNDirector/PDMR Shareholding
19th Mar 20247:00 amPRNTransaction in Own Shares
18th Mar 20247:00 amPRNTransaction in Own Shares
15th Mar 20247:10 amRNSLaunch of £60 million Share Buyback Programme
15th Mar 20247:00 amRNSFull year results for year ended 31 December 2023
11th Mar 20247:00 amPRNBoard Change
1st Mar 20249:27 amPRNDirector Declaration
29th Feb 20244:30 pmPRNTotal Voting Rights
31st Jan 20244:30 pmPRNTotal Voting Rights
31st Jan 20243:57 pmPRNBodycote plc - Holding(s) in Company
22nd Jan 20247:00 amRNSAcquisition Update and Share Buyback Programme
8th Jan 20244:37 pmPRNHolding(s) in Company
29th Dec 202312:25 pmPRNTotal Voting Rights
8th Dec 20234:40 pmPRNDirector/PDMR Shareholding
30th Nov 20234:30 pmPRNTotal Voting Rights
22nd Nov 20237:00 amRNSTrading Update
10th Nov 202312:08 pmPRNDirector/PDMR Shareholding
9th Nov 20237:00 amRNSDirector Declaration
31st Oct 20234:30 pmPRNTotal Voting Rights
31st Oct 202310:07 amPRNDirector/PDMR Shareholding
18th Oct 20237:00 amRNSGroup Chief Executive Appointment
9th Oct 20237:00 amRNSSpecialist Tech Acquisitions & New HIP Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.